Epirubicin Ebewe

Epirubicin Hydrochloride is a chemotherapy drug used for treating various cancers. This intravenous or intravesical medication is manufactured by Ebewe Pharma in the EU.

Epirubicin Hydrochloride is primarily used in cancer treatment, targeting cells to slow or stop their growth. It is administered intravenously for systemic effects or intravesically for localized bladder cancer treatment. The drug is often part of combination therapies for breast, stomach, and lung cancers.

Common effects of Epirubicin Hydrochloride may include nausea, vomiting, and fatigue. Some patients experience hair loss or changes in skin color. Severe side effects, such as heart problems or infections, are less common but require immediate medical attention.

Epirubicin Hydrochloride should be handled with care to avoid contamination. It is essential to follow healthcare provider instructions for administration and monitoring. Patients should report any unusual symptoms promptly.

Epirubicin Hydrochloride may interact with other medications, including those that affect the heart or immune system. Alcohol and certain supplements can also influence its effects. Always inform healthcare providers about all medications being taken.